Abstract:Nicotinamide adenine dinucleotide (NAD+) is an essential metabolite with wide-ranging and significant roles in the cell. Defects in NAD+ metabolism have been associated with many human disorders; it is therefore an emerging therapeutic target. Moreover, NAD+ metabolism is perturbed during colonization by a variety of pathogens, either due to the molecular mechanisms employed by these infectious agents or by the host immune response they trigger. Three main biosynthetic pathways, including the de novo and salvage pathways, contribute to the production of NAD+ with a high degree of conservation from bacteria to humans. De novo biosynthesis, which begins with l-tryptophan in eukaryotes, is also known as the kynurenine pathway. Intermediates of this pathway have various beneficial and deleterious effects on cellular health in different contexts. For example, dysregulation of this pathway is linked to neurotoxicity and oxidative stress. Activation of the de novo pathway is also implicated in various infections and inflammatory signaling. Given the dynamic flexibility and multiple roles of NAD+ intermediates, it is important to understand the interconnections and cross-regulations of NAD+ precursors and associated signaling pathways to understand how cells regulate NAD+ homeostasis in response to various growth conditions. Although regulation of NAD+ homeostasis remains incompletely understood, studies in the genetically tractable budding yeast Saccharomyces cerevisiae may help provide some molecular basis for how NAD+ homeostasis factors contribute to the maintenance and regulation of cellular function and how they are regulated by various nutritional and stress signals. Here we present a brief overview of recent insights and discoveries made with respect to the relationship between NAD+ metabolism and selected human disorders and infections, with a particular focus on the de novo pathway. We also discuss how studies in budding yeast may help elucidate the regulation of NAD+ homeostasis.

Targeting NAD+ Metabolism to Modulate Autoimmunity and Inflammation

The Role of Nicotinamide Adenine Dinucleotide in the Pathogenesis of Rheumatoid Arthritis: Potential Implications for Treatment

NAD+ Metabolism and Immune Regulation: New Approaches to Inflammatory Bowel Disease Therapies

The Role of NAD+ and NAD+-Boosting Therapies in Inflammatory Response by IL-13

Targeting NAD+ in Metabolic Disease: New Insights Into an Old Molecule

NAD+ metabolism, stemness, the immune response, and cancer

NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential

Boosting NAD preferentially blunts Th17 inflammation via arginine biosynthesis and redox control in healthy and psoriasis subjects

NAD+ Precursors and Intestinal Inflammation: Therapeutic Insights Involving Gut Microbiota

SIRT1: A Potential Therapeutic Target in Autoimmune Diseases

Macrophage de novo NAD+ synthesis specifies immune function in aging and inflammation

Targeting NAD Metabolism for the Therapy of Age-Related Neurodegenerative Diseases

Regulation of and challenges in targeting NAD + metabolism

NAD+ metabolism and its roles in cellular processes during ageing

NAD+ Metabolism, Metabolic Stress, and Infection

NAD metabolism modulates inflammation and mitochondria function in diabetic kidney disease

NAD+ Deficiency Is a Common Central Pathological Factor of a Number of Diseases and Aging: Mechanisms and Therapeutic Implications

Decoding NAD+ Metabolism in COVID-19: Implications for Immune Modulation and Therapy

NAD+ centric mechanisms and molecular determinants of skeletal muscle disease and aging

NAD+ homeostasis in health and disease

NAD metabolism: Role in senescence regulation and aging